Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis

Clinical trial NCT01684761 · COMPLETED

Trial details

NCT number: NCT01684761
Sponsor: Opexa Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Diseases of the Nervous System Multiple Sclerosis Secondary Progressive Multiple Sclerosis Disease Progression Brain Atrophy

Start date: 2012-08-01
Primary completion: 2016-10-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.